Biohaven (NYSE:BHVN) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Biohaven (BHVN): Assessing Valuation After Recent Share Price Boost [Yahoo! Finance]
Biohaven (NYSE:BHVN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Biohaven (NYSE:BHVN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Biohaven (NYSE:BHVN) had its price target lowered by analysts at JPMorgan Chase & Co. from $47.00 to $15.00. They now have an "overweight" rating on the stock.